Molecular viable count testing in Pseudomonas chronic bronchial infection (360G-Wellcome-202457_Z_16_Z)
In this project, a novel Molecular Bacterial Load (MBL) assay that is able to quantify viable Pseudomonas in samples will be developed. Primers will specifically target the 16SrRNA in Pseudomonas bacteria. This will allow the assay to determine the presence of Pseudomonas bacteria in samples, as well as quantify the number of organisms that are alive. Compared to current techniques for determining the presence and viability of organisms in acute and chronic Pseudomonas infections, the MBL assay will provide results significantly faster, and will be much more specific. This means that the technology could be applied clinically as a new tool to monitor the response of patient to antimicrobial therapy, and ensure that there is not resistance to the selected treatment. This is relevant particularly in patients with chronic respiratory disease such as Cystic Fibrosis, where a chronic (and inadequately treated) Pseudomonas infection can significantly increase morbidity and risk of mortality. Key objectives for this project include: developing a 16SrRNA primer for Pseudomonas to be used in the MBL assay; to determine the specificity of the assay by testing it against organisms that are taxonomically related to Pseudomonas; and to validate the assay with a pre-existing clinical sample set.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
Amount Awarded | 2000 |
Applicant Surname | Karmen |
Approval Committee | Internal Decision Panel for C&S |
Award Date | 2016-04-01T00:00:00+00:00 |
Financial Year | 2015/16 |
Grant Programme: Title | Vacation Scholarships |
Internal ID | 202457/Z/16/Z |
Lead Applicant | Miss Lindsey Karmen |
Partnership Value | 2000 |
Planned Dates: End Date | 2016-07-31T00:00:00+00:00 |
Planned Dates: Start Date | 2016-06-06T00:00:00+00:00 |
Recipient Org: Country | United Kingdom |
Region | Scotland |